NASDAQ:SBBP

Strongbridge Biopharma (SBBP) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.95
$2.06
50-Day Range
$1.89
$2.29
52-Week Range
$1.85
$4.26
Volume
684,684 shs
Average Volume
866,464 shs
Market Capitalization
$135.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SBBP stock logo

About Strongbridge Biopharma Stock (NASDAQ:SBBP)

Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA.

SBBP Stock News Headlines

Matinas BioPharma Holdings Inc (MTNB)
Lytix Biopharma As Share Price (LYTIX.OL)
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Ambrx Biopharma Inc AMAM
HILS Hillstream BioPharma, Inc.
ABUS - Arbutus Biopharma Corporation
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
See More Headlines
Receive SBBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Strongbridge Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/05/2021
Today
4/23/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SBBP
Fax
N/A
Employees
72
Year Founded
N/A

Profitability

Net Income
$-45,080,000.00
Net Margins
-115.67%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$30.73 million
Book Value
$0.98 per share

Miscellaneous

Free Float
N/A
Market Cap
$135.66 million
Optionable
Optionable
Beta
1.58
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • John H. Johnson
    Chief Executive Officer & Director
  • Richard S. Kollender
    President & Chief Financial Officer
  • Fredric Cohen
    Chief Medical Officer
  • Brian Conner
    Chief Compliance Officer
  • Peter J. Valentinsson
    Senior Vice President-Global Technical Operations

SBBP Stock Analysis - Frequently Asked Questions

How were Strongbridge Biopharma's earnings last quarter?

Strongbridge Biopharma plc (NASDAQ:SBBP) released its earnings results on Thursday, August, 5th. The biotechnology company reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.09. The biotechnology company had revenue of $10.04 million for the quarter, compared to analysts' expectations of $8.83 million. Strongbridge Biopharma had a negative net margin of 115.67% and a negative trailing twelve-month return on equity of 66.82%.

What other stocks do shareholders of Strongbridge Biopharma own?
This page (NASDAQ:SBBP) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners